[1]曹 燕,刘冰妍,茅爱武,等.急性结肠梗阻支架置入对结直肠癌择期手术的作用[J].介入放射学杂志,2011,(10):799.
　CAO Yan,LIU Bin-yan,MAO Ai-wu,et al.Metallic stent placement for the management of acute colorectal obstruction caused by colorectal carcinomas: its effect on scheduled surgery[J].journal interventional radiology,2011,(10):799.
点击复制

急性结肠梗阻支架置入对结直肠癌择期手术的作用()

PDF下载中关闭

分享到：

《介入放射学杂志》[ISSN:1008-794X/CN:31-1796/R]

卷:
期数:
2011年10期
页码:
799
栏目:
非血管介入
出版日期:
2011-10-25

文章信息/Info

Title:
Metallic stent placement for the management of acute colorectal obstruction caused by colorectal carcinomas: its effect on scheduled surgery
作者:
曹 燕;  刘冰妍;  茅爱武;  殷 响;  高中度
200050 上海长宁区同仁医院介入科
Author(s):
CAO Yan;  LIU Bin-yan;  MAO Ai-wu;  YIN Xiang;  GAO Zhong-du
Department of Interventional Center, Shanghai ST. Luke’s Hospital, Shanghai 200050, China
关键词:
癌; 　肠、　结直肠; 　自膨胀金属支架; 　恶性梗阻; 　外科学
分类号:
Ｒ７３５.３５
文献标志码:
A
摘要:
目的　　　探讨自膨胀金属支架（ＳＥＭＳ）置入对结直肠癌患者所致急性结肠梗阻择期手术的作用。方法　　　２００１年４月－　２０１０年１２月，对急性结肠梗阻、拟择期手术的５２例结直肠癌患者使用自膨胀金属支架治疗。收集患者的相关数据，包括技术和临床疗效、并发症、择期外科手术成功率及生存时间。结果　　　５２例中除２例完全梗阻外，其余支架置入均获得技术成功，且无手术相关并发症，技术成功率为９６％（５０／５２）。支架植入后２　ｄ内，技术成功的５０例患者中４９例患者肠梗阻解除。不良反应有４例支架移位，２例肛门疼痛，１例粪便堆积，通过肠镜疏通得以解决。５０例患者在自膨胀金属支架置入后的（８　±　２）ｄ（４　～　１１　ｄ）内择期行肿瘤根治术。随访（３６　±　１２）个月（３　～　７０个月），所有患者均存活。结论　　　新型自膨胀金属支架对治疗结直肠癌所致急性结肠梗阻择期手术患者安全、有效，同时能确保大多数患者择期外科根治手术的成功实施。

参考文献/References:

[1] Deans GT, Krukowski ZH, Irwin ST. Malignant obstruction of the left colon[J]. Br J Surg, 1994, 81: 1270 - 1276.
[2] Leitman IM, Sullivan JD, Brams D, et al. Multivariate analysis of morbidity and mortality from the initial surgical management of obstructing carcinoma of the colon[J]. Surg Gynaecol Obstet, 1992, 174: 513 - 518.
[3] Chen HS, Sheen SC. Obstruction and perforation in colorectal adenocarcinoma: an analysis of prognosis and current trends[J]. Surgery, 2000, 127: 370 - 376.
[4] Horiuchi A, Nakayama Y, Tanaka N, et al. Acute colorectal obstruction treated by means of transanal drainage tube: effectiveness before surgery and stenting[J]. Am J Gastroenterol, 2005, 100: 2765 - 2770.
[5] Lee KM, Shin SJ, Hwang JC, et al. Comparison of uncovered stent with covered stent for treatment of malignant colorectal obstruction[J]. Gastrointest Endosc, 2007, 66: 931 - 936.
[6] Repici A, De CG, Luigiano C, et al. Wallflex colonic stent placement for management of malignant colonic obstruction: a prospective study at two centers[J]. Gastrointest Endosc, 2008, 67: 77 - 84.
[7] Fregonese D, Naspetti R, Ferrer S, et al. Ultraflex precision colonic stent placement as a bridge to surgery in patients with malignant colon obstruction[J]. Gastrointest Endosc, 2008, 67: 68 - 73.
[8] Fischer A, Schrag HJ, Goos M, et al. Transanal endoscopic tube decompression of acute colonic obstruction: experience with 51 cases[J]. Surg Endosc, 2008, 22: 683 - 688.
[9] Song HY, Kim JH, Shin JH, et al. A dual-design expandable colorectal stent for malignant colorectal obstruction: results of a multicenter study[J]. Endoscopy, 2007, 39: 448 - 454.
[10] Athreya S, Moss J, Urquhart G, et al. Colorectal stenting for colonic obstruction: the indications,complications,effectiveness and outcome-5 year review[J]. Eur J Radiol, 2006, 60: 91 - 94.
[11] Soto S, López LR, González AR, et al. Endoscopic treatment of acute colorectal obstruction with self-expandable metallic stents: experience in a community hospital[J]. Surg Endosc, 2006, 20: 1072 - 1076.
[12] Meisner S, Hensler M, Knop FK, et al. Self-expanding metal stents for colonic obstruction: experiences from 104 procedures in a single center[J]. Dis Colon Rectum, 2004, 47: 444 - 450.
[13] Khot UP, Lang AW, Murali K, et al. Systematic review of the efficacy and safety of colorectal stents[J]. Br J Surg, 2002, 89: 1096 - 1102.
[14] Baron HT, Kozarek AR. Endoscopic stenting of colonic tumours[J]. Best Pract Res Clin Gastroenterol, 2004, 18: 209 - 229.
[15] Sebastian S, Johnston S, Geoghegan T, et al. Pooled analysis of the efficacy and safety of self-expanding metal stenting in malignant colorectal obstruction[J]. Am J Gastroenterol, 2004, 99: 2051 - 2057.
[16] van Hooft JE, Fockens P, Marinelli AW, et al. Premature closure of the Dutch stent-in I study[J]. Lancet, 2006, 368: 1573 - 1574.

相似文献/References:

[1]程红岩 徐爱民 陈栋 贾雨辰.根据大肝癌血供特点决定TACE时碘油剂量的可行性研究[J].介入放射学杂志,2003,(05):357.
[2]汪志良 范晔 曹军 闫丽萍 杨雅.晚期及术后复发乳腺癌的介入治疗[J].介入放射学杂志,2004,(02):147.
[3]卢伟 李彦豪 何晓峰 陈勇.小剂量与常规剂量化疗药物经导管栓塞化疗对肝癌患者血清肝纤维化指标的影响[J].介入放射学杂志,2004,(03):247.
[4]肖恩华 胡国栋 胡道予 刘鹏程 刘绍春 郝春荣.化疗栓塞对肝细胞癌上皮型钙粘蛋白表达的影响[J].介入放射学杂志,2001,(01):20.
[5]程红岩 陈栋 徐爱民 贾雨辰.大剂量碘油治疗大肝癌的初步体会[J].介入放射学杂志,2002,(01):24.
[6]申淑群,杨业发,葛乃建,等.肝癌破裂出血的介入与外科手术疗效评价[J].介入放射学杂志,2010,(07):544.
　SHEN Shuqun,YANG Yefa,GE Naijian,et al.Evaluation of interventional and surgical treatments for the hemorrhage of ruptured hepatocellular carcinoma[J].journal interventional radiology,2010,(10):544.
[7]方 瑜,龙清云,刘骏方,等.肝癌合并肝动脉-肝门静脉瘘介入治疗方式的探讨[J].介入放射学杂志,2010,(10):776.
　FANG Yu,LONG Qing-yun,LIU Jun-fang,et al.Exploration of interventional therapeutic pattern for hepatocellular carcinoma associated with hepatic arterioportal fistulae[J].journal interventional radiology,2010,(10):776.
[8]张庆凡,姜朝晖,缪建良,等.经淋巴管免疫化疗治疗淋巴转移癌[J].介入放射学杂志,1998,(01):25.
[9]熊正平 张阳德 黄芳 杨树仁 梁赵玉 刘辉 何庆.肝细胞癌化疗栓塞后胰岛素样生长因子-2与转移关系的研究[J].介入放射学杂志,2006,(10):597.
　XIONG Zheng-ping ZHANG Yang-de HUANG Fang YANG Shu-ren LIANG Zhao-yu LIU Hui HE Qing.Relation between insulin-like growth factor-2 and metastases after transcatheter arterial chemoembolization in patients with hepatocellular carcinoma[J].journal interventional radiology,2006,(10):597.
[10]于永江 范荣 王丽英 王德本 岳玲.亚段性经导管动脉化疗栓塞术治疗中晚期原发性肝癌的临床研究[J].介入放射学杂志,2002,(05):348.

备注/Memo

备注/Memo:
收稿日期：２０１１０４０８
更新日期/Last Update: 2011-10-25